Main
>
ONCOLOGY (**)
>
MyeloDysplastic Syndromes ***
>
Treatment
>
USA. C. Lenalidomide
USA. C. Lenalidomide's subsections
(*) USA Approval Date: ?
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 17
Patent>UpDate: 2018. 11.06.
TradeMark
TradeMark Web-Site
USA. C. Lenalidomide's products
This section has no products
(*) USA Approval Date: ?
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 17
Patent>UpDate: 2018. 11.06.
TradeMark
TradeMark Web-Site